| Literature DB >> 35206093 |
Zhong Wu1,2, Wenzhi Zeng3, Xun Zhang2, Jiangfan Yang1.
Abstract
A bioactive acidic tea polysaccharide from yellow leaves of Wuyi rock tea was successively prepared via DEAE-52 and Superdex-200 columns. Nuclear magnetic resonance (NMR) analysis showed that the main glycosidic bonds were composed of α-l-Araf-(1→, →5)-α-l-Araf-(1→, →4)-α-d-Glcp-(1→, Arap-(1→, →6)-α-d-Glcp-(1→, →2,4)-α-l-Rhap-(1→, →3,4)-α-d-Glcp-(1→, →4)-α-d-GalAp-(1→, →4)-α-d-GalAp-(1→, α-d-Galp-(1→, →6)-β-d-Galp-(1→ and →4)-β-d-Galp-(1→. The molecular weight was 3.9285 × 104 Da. The hypoglycemic effect of acidic tea polysaccharides on streptozotocin-induced type 2 diabetes mellitus rats was evaluated through histopathology and biochemistry analysis. The acidic tea polysaccharide could improve plasma and liver lipid metabolism. Moreover, 16S rRNA gene sequencing revealed that the composition of the intestinal flora changed drastically after treatment, namely, blooms of Bifidobacterium, Blautia, Dorea, and Oscillospira, and a strong reduction in Desulfovibrio and Lactobacillus. The above results illustrated that tea polysaccharides might serve as an effective ingredient to ameliorate glucose metabolism disorders and intestinal flora in hyperglycemic rats.Entities:
Keywords: acidic tea polysaccharides; hyperglycemia; intestinal flora; structure characterization
Year: 2022 PMID: 35206093 PMCID: PMC8871580 DOI: 10.3390/foods11040617
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Figure 1Elution diagram of DEAE-52.
Figure 2HPGPC chromatogram of the polysaccharide from yellow leaves of Wuyi rock tea (CY).
HPGPC analysis of CY.
| Sample ID | RT(min) | lgMp | lgMw | lgMn | Mp | Mw | Mn |
|---|---|---|---|---|---|---|---|
| 39.76 | 4.5 | 4.6 | 4.5 | 32,729 | 39,285 | 28,224 |
Figure 3Ion chromatogram of mixed monosaccharide standards. 1. Fuc, 2. Rha, 3. Ara, 4. GlcN, 5. Gal, 6. Glc, 7. GlcNAc, 8. Xyl, 9. Man, 10. Fru, 11. Rib, 12. GalA, 13. GlcA.
Figure 4Ion chromatogram of component monosaccharides released from CY. 1. Rha, 2. Ara, 3. Gal, 4. Glc, 5. GalA.
Monosaccharide Composition Analysis of CY.
| Name | RT | Linear | R2 | Range (μg/mL) | Molar Ratio | Quality Ratio (%) |
|---|---|---|---|---|---|---|
| Fucose (Fuc) | 5.875 | y = 0.184x + 0.98 | 0.990 | 1–100 | 0.000 | 0.000 |
| Rhamnose (Rha) | 11.75 | y = 0.089x + 0.226 | 0.996 | 1–100 | 0.086 | 7.680 |
| Arabinose (Ara) | 12.742 | y = 0.243x + 1.096 | 0.990 | 1–100 | 0.124 | 10.127 |
| Glucosamine hydrochloride (GlcN) | 14.067 | y = 0.427x + 1.963 | 0.992 | 1–100 | 0.000 | 0.000 |
| Galactose (Gal) | 16.275 | y = 0.242x + 1.161 | 0.997 | 1–100 | 0.143 | 14.014 |
| Glucose (Glc) | 18.417 | y = 0.259x + 1.715 | 0.990 | 1–100 | 0.020 | 1.961 |
| N-acetyl-d-glucosamine (GlcNAc) | 19.717 | y = 0.195x + 0.549 | 0.997 | 1–100 | 0.000 | 0.000 |
| Xylose (Xyl) | 21.55 | y = 0.152x + 0.815 | 0.993 | 1–100 | 0.000 | 0.000 |
| Mannose (Man) | 22.384 | y = 0.095x + 0.331 | 0.996 | 1–100 | 0.000 | 0.000 |
| Fructose (Fru) | 25.809 | y = 0.075x − 0.148 | 0.997 | 1–100 | 0.000 | 0.000 |
| Ribose (Rib) | 27.859 | y = 0.62x − 0.494 | 0.996 | 1–100 | 0.000 | 0.000 |
| Galacturonic acid (GalA) | 45.542 | y = 0.155x + 0.004 | 1.000 | 1–100 | 0.627 | 66.218 |
| Glucuronic acid (GlcA) | 49.075 | y = 0.192x + 0.195 | 0.999 | 1–100 | 0.000 | 0.000 |
Figure 5FTIR spectra of tea polysaccharide (CY).
Figure 6Type of polysaccharide linkage. 1. Araf-(1→ 2. Arap-(1→ 3. →5)-Araf-(1→ 4. Galp-(1→ 5. →2,4)-Rhap-(1→ 6. →4)-Galp-(1→ 7. →4)-Glcp-(1→ 8. →6)-Galp-(1→ 9. →3,4)-Glcp-(1→ 10. →4,6)-Glcp-(1→.
The methylation of CY.
| Retention Time (min) | Methylated Sugar | Mass Fragments ( | Molar Ratio | Type of Linkage |
|---|---|---|---|---|
| 9.45 | 2,3,5-Me3-Araf | 43, 71, 87, 101, 117, 129, 145, 161 | 2.54 | Araf-(1→ |
| 10.856 | 2,3,4-Me3-Arap | 43, 71, 87, 101, 117, 129, 131, 161 | 8.31 | Arap-(1→ |
| 14.435 | 2,3-Me2-Araf | 43, 71, 87, 99, 101, 117, 129, 161, 189 | 3.10 | →5)-Araf-(1→ |
| 17.425 | 2,3,4,6-Me4-Galp | 43, 71, 87, 101, 117, 129, 145, 161, 205 | 8.49 | Galp-(1→ |
| 18.515 | 3-Me1-Rhap | 43, 87, 101, 117, 129, 143, 159, 189 | 8.37 | →2,4)-Rhap-(1→ |
| 18.747 | 2,3,6-Me3-Galp | 43, 87, 99, 101, 113, 117, 129, 131, 161, 173, 233 | 42.15 | →4)-Galp-(1→ |
| 21.107 | 2,3,6-Me3-Glcp | 43, 87, 99, 101, 113, 117, 129, 131, 161, 173, 233 | 5.40 | →4)-Glcp-(1→ |
| 21.345 | 2,3,4-Me3-Galp | 43, 87, 99, 101, 117, 129, 161, 189, 233 | 9.98 | →6)-Galp-(1→ |
| 24.278 | 2,6-Me2-Glcp | 43, 87, 97, 117, 159, 185 | 3.06 | →3,4)-Glcp-(1→ |
| 27.762 | 2,3-Me2-Glcp | 43, 71, 85, 87, 99, 101, 117, 127, 159, 161, 201 | 8.60 | →4,6)-Glcp-(1→ |
Figure A11H- (a) and 13C-NMR (b), DEPT135 (c), HSQC (d), and COSY (e) spectra of CY in D2O.
Assignment of 13C and 1H chemical shifts of CY.
| Glycosyl Residues | H1 | H2 | H3 | H4 | H5a/H5 | H5b/6a | H6b | CH3 | CH3CO |
|---|---|---|---|---|---|---|---|---|---|
| C1 | C2 | C3 | C4 | C5 | C6 | ||||
| α-L-Araf-(1→ | 5.17 | 4.13 | 3.87 | 4.06 | 3.76 | 3.64 | |||
| 110.62 | 82.62 | 77.97 | 85.22 | 62.64 | |||||
| →5)-α-L-Araf-(1→ | 5.04 | 4.07 | 3.96 | 4.16 | 3.84 | 3.75 | |||
| 108.6 | 82.52 | 78.12 | 83.6 | 68.09 | |||||
| →4)-α-D-Glcp-(1→ | 5.31 | 3.5 | 3.86 | 3.55 | 3.76 | 3.73 | 3.76 | ||
| 100.88 | 72.75 | 74.53 | 77.98 | 72.45 | 61.73 | ||||
| Arap-(1→ | 5.09 | ||||||||
| 108.76 | |||||||||
| →6)-α-D-Glcp-(1→ | 4.89 | 3.48 | 3.63 | 3.44 | 3.83 | 3.9 | 3.66 | ||
| 99.14 | 72.84 | 74.7 | 70.98 | 71.44 | 66.79 | ||||
| →2,4)- α-L-Rhap-(1→ | 5.2 | 4.04 | 4.02 | 4.33 | 3.8 | 18 | |||
| 99.72 | 77.57 | 71.63 | 78.47 | 70.87 | 1.17 | ||||
| →3,4)-α-D-Glcp-(1→ | 4.95 | 3.8 | 4.03 | 4.36 | 4.7 | 18 | |||
| 99.14 | 70.75 | 77.48 | 80.11 | 72.97 | 1.17 | ||||
| →4)-α-D-GalAp-(1→ | 4.88 | 3.66 | 3.91 | 4.36 | 5.05 | 3.73 | 1.96 | ||
| 101.7 | 69.54 | 69.79 | 80.06 | 72.09 | 172.13 | 54.29 | 21.2 | ||
| →4)-α-D-GalAp-(1→ | 5.04 | 3.73 | 3.94 | 4.52 | 4.6 | ||||
| 101.87 | 69.8 | 70.1 | 80.78 | 72.92 | 176.24 | ||||
| α-D-Galp-(1→ | 5.04 | 3.73 | 3.94 | 4.03 | 4.6 | 3.66 | 3.75 | ||
| 101.87 | 69.8 | 70.1 | 71.74 | 72.92 | 62.77 | ||||
| →6)-β-D-Galp-(1→ | 4.37 | 3.44 | 3.58 | 3.86 | 3.88 | 3.61 | 3.83 | ||
| 104.9 | 72.16 | 73.93 | 74.96 | 69.87 | 76.1 | ||||
| →4)-β-D-Galp-(1→ | 4.56 | 3.6 | 3.7 | 4.08 | 3.65 | 3.74 | |||
| 105.74 | 73.12 | 74.61 | 79.05 | 75.81 | 62.11 |
The effects of CY on the blood glucose of hyperglycemic rats ( ± s).
| Group | Blood Glucose Concentration/(mmol/L) | ||||
|---|---|---|---|---|---|
| 0 d | 10 d | 20 d | 30 d | 40 d | |
| NC | 5.14 ± 0.16 | 4.78 ± 0.49 | 5.28 ± 0.53 | 4.82 ± 0.76 | 5.19 ± 1.11 |
| DC | 24.45 ± 3.87 ΔΔ | 25.27 ± 3.61 ΔΔ | 23.56 ± 5.02 ΔΔ | 24.32 ± 5.27 ΔΔ | 24.17 ± 3.13 ΔΔ |
| ME | 27.47 ± 3.56 | 26.36 ± 4.68 | 22.05 ± 2.67 | 19.16 ± 3.85 | 16.01 ± 2.78 * |
| LT | 25.74 ± 2.13 | 23.17 ± 4.93 | 21.22 ± 4.02 | 19.37 ± 4.45 | 19.42 ± 3.38 |
| MT | 27.30 ± 2.02 | 22.73 ± 5.17 | 20.81 ± 4.29 | 19.87 ± 4.78 | 17.12 ± 2.15 * |
| HT | 28.65 ± 4.78 | 27.54 ± 3.94 | 23.56 ± 4.05 | 18.97 ± 3.15 | 19.25 ± 3.02 |
Note: (1) 0 d shows the blood glucose values before treatment; 10 d, 20 d, 30 d, and 40 d show the blood glucose values at 10, 20, 30, and 40 days of drug administration, respectively; (2) ΔΔ represents highly significant difference (p < 0.01) between DC group and NC group control. * Represents a significant difference (p < 0.05) between the drug administration group and DC group.
The effects of CY on glucose tolerance of hyperglycemic rats ( ± s).
| Groups | Blood Glucose Concentration/(mmol/L) | ||||
|---|---|---|---|---|---|
| 0 min | 30 min | 60 min | 120 min | AUC | |
| NC | 4.49 ± 1.20 | 5.72 ± 0.93 | 5.31 ± 0.62 | 4.62 ± 0.54 | 7.79 ± 1.18 |
| DC | 22.86 ± 2.74 ΔΔ | 31.27 ± 2.65 ΔΔ | 23.68 ± 2.77 ΔΔ | 23.22 ± 3.26 ΔΔ | 39.00 ± 3.52 ΔΔ |
| ME | 15.78 ± 1.88 * | 22.62 ± 1.82 * | 20.59 ± 2.16 | 16.20 ± 2.00 * | 29.60 ± 2.26 ** |
| LT | 18.85 ± 2.69 | 25.53 ± 2.72 | 23.64 ± 3.28 | 19.92 ± 2.56 | 34.27 ± 3.05 * |
| MT | 17.53 ± 1.84 | 24.17 ± 2.21 * | 22.18 ± 2.09 | 18.67 ± 1.94 | 32.23 ± 2.74 ** |
| HT | 17.68 ± 2.26 | 25.58 ± 3.14 | 21.91 ± 2.55 | 19.32 ± 2.91 | 32.99 ± 3.32 ** |
Note: (1) 0 min shows the blood glucose values before treatment; 30 min, 60 min, and 120 min show the blood glucose values at 30, 60, and 120 min of drug administration, respectively; (2) ΔΔ represents highly significant difference (p < 0.01) between DC group and NC group control. * Represents a significant difference (p < 0.05); ** represents a highly significant difference (p < 0.01) between the drug administration group and DC group.
The effects of CY on biochemical indices in diabetic rats.
| Group | Biochemical Indices | |||||
|---|---|---|---|---|---|---|
| TG | TC | LDL-C | HDL-C | AST | ALT | |
| NC | 0.57 ± 0.15 | 2.17 ± 0.13 | 0.55 ± 0.07 | 1.58 ± 0.16 | 142.80 ± 8.96 | 93.24 ± 9.57 |
| DC | 3.99 ± 0.28 ΔΔ | 3.56 ± 0.35 | 1.36 ± 0.11 ΔΔ | 1.08 ± 0.17 Δ | 198.00 ± 31.27 | 107.05 ± 13.74 |
| ME | 2.19 ± 0.06 ** | 2.74 ± 0.16 | 0.77 ± 0.08 ** | 1.17 ± 0.20 | 123.54 ± 11.52 | 79.61 ± 9.63 |
| LT | 2.91 ± 0.25 * | 2.54 ± 0.47 | 1.27 ± 0.13 | 1.29 ± 0.25 | 128.43 ± 9.12 | 87.94 ± 5.46 |
| MT | 2.67 ± 0.17 ** | 2.55 ± 0.38 | 1.25 ± 0.02 | 1.29 ± 0.11 | 117.73 ± 6.82 * | 86.90 ± 5.75 |
| HT | 2.85 ± 0.13 * | 2.61 ± 0.32 | 0.87 ± 0.12 * | 1.23 ± 0.19 | 127.30 ± 14.06 | 75.36 ± 5.26 |
Note: Δ represents a significant difference (p < 0.05); ΔΔ represents a highly significant difference (p < 0.01) between the DC group and NC group control; * represents a significant difference (p < 0.05) between the drug administration group and DC group; ** represents a highly significant difference (p < 0.01).
Figure 7The effects of CY on liver cell morphology in diabetic rats (×200). (a) NC; (b) DC; (c) ME; (d) LT; (e) MT; (f) HT.
Figure 8The effects of CY on pancreatic islet morphology in diabetic rats (×200). (a) NC; (b) DC; (c) ME; (d) LT; (e) MT; (f) HT.
Figure A2Phylum- and genus-level distributions of fecal microbiota. (a) Phylum-level distribution; (b) genus-level distribution.
Figure A3Grouped box plot of Alpha Diversity Index.Note: Each panel corresponds to an alpha diversity index, which is identified in the gray area at the top of the panel. The numbers under the diversity index label are the p values of the Kruskal–Wallis test. * represents a significant difference between the subgroup below it and the whole formed by the samples of all the remaining subgroups (p < 0.05); ** represents a highly significant difference (p < 0.01); *** represents a highly significant difference (p < 0.001).
Figure 9PCoA of weighted distance.
Figure 10NMDS two-dimensional sorting diagram. Note: Each dot in the figure represents a sample, and dots of different colors indicate different treatment groups. Dashed oval circles are 95% confidence ellipses.
Figure A4Heatmap of species composition at the genus level.
Figure A5Linear discriminant analysis effect size (LEfSe) analysis of rat intestinal flora. (a) Histogram of LDA effect values for marker species; (b) display diagram of intergroup difference classification units based on classification hierarchy tree.
Figure A6The heatmap of the top 20 most important genera.
Figure 11Zi-Pi scatter plot.
Figure A7Intergroup differences in the KEGG metabolic pathway. (a) DC vs. NC; (b) DC vs. ME; (c) DC vs. LT; (d) DC vs. MT; (e) DC vs. HT. Note: Positive values of logFC on the horizontal axis represent upregulation (log2(fold change)) in DC group relative to group of NC, ME, LT, MT, and HT, respectively, and negative values are downregulation; vertical coordinates are different KEGG metabolic pathway labels; the degree of significance is shown in different colors.